Evidence

Displaying 11 - 20 of 120, sorted by most recent

form.antibot { display: none !important; } You must have JavaScript enabled to use this form.

COVID-19 and the U.S. District Courts: An Empirical Investigation

Roy P. Germano, Timothy T. Lau, Kristin A. Garri

October 29, 2022

This report uses caseload data to examine case-processing trends in the United States district courts during the COVID-19 pandemic.

Term Talk: U.S. v. Zubaydah, F.B.I. v. Fazaga

Paul Clement, James A. Chance

September 14, 2022

State Secrets Privilege. FISA. Experts discuss the interplay between the common law State Secrets Privilege and the statutory Foreign Intelligence Surveillance Act (FISA).

Amendments to the Federal Rules of Practice and Procedure 2023—Transmittal to the Judicial Conference

August 23, 2022

This package of materials was transmitted to the Judicial Conference, and it includes proposed amendments to the Federal Rules of Practice and Procedure to become effective on December 1, 2023.

Case Commentary: Nowlan v. Nowlan, Civil Action No. 5:20cv00102, 2021 U.S. Dist. LEXIS 10824 (W.D. Va. Jan. 21, 2021)

James D. Garbolino

March 19, 2021

Videoconference Testimony | Sixth Amendment Right to Confront and the Hague Convention

In this case, the petitioner made a pretrial request to appear by videoconference.

Holdings

Case Commentary: Pope v. Lunday, No. 20-6003, 2020 U.S. App. LEXIS 36618 (10th Cir. Nov. 20, 2020)

James D. Garbolino

February 16, 2021

Habitual Residence of Infants | Lack of Necessity of Evidentiary Hearing

Opioid Crisis: Biology, Neurobiology, and Chemistry of Opioid Use Disorder

Wilson Compton, Jason A. Cantone

December 3, 2020

Dr. Wilson Compton, deputy director of the National Institute on Drug Abuse (NIDA), explains what judges need to know about the biology, neurobiology, and chemistry of opioid use disorder.

Opioid Crisis: Summary

Irene M. Keeley

December 3, 2020

In concluding remarks, Judge Irene Keeley (N.D. W.

Opioid Crisis: Treatment of Incarcerated Individuals with Opioid Use Disorders

Cathy Thompson

December 3, 2020

Dr.

Opioid Crisis: Understanding the Issue

Robert Redfield, Hanna Umanskiy Ortiz

December 3, 2020

Dr. Robert Redfield, director of the Centers for Disease Control and Prevention (CDC), identifies drug use disorder as the public health crisis of our time.

Opioid Crisis: Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings

Christopher Jones, Hanna Umanskiy Ortiz

December 3, 2020

Dr. Christopher Jones, U.S. Public Health Service and Centers for Disease Control and Prevention (CDC), reviews current options (to include methadone, buprenorphine and naltrexone) in Medication-Assisted Treatment (MAT) for those with an opioid use disorder.

Federal Judicial Center

You are here

Evidence

COVID-19 and the U.S. District Courts: An Empirical Investigation

Term Talk: U.S. v. Zubaydah, F.B.I. v. Fazaga

Amendments to the Federal Rules of Practice and Procedure 2023—Transmittal to the Judicial Conference

Case Commentary: Nowlan v. Nowlan, Civil Action No. 5:20cv00102, 2021 U.S. Dist. LEXIS 10824 (W.D. Va. Jan. 21, 2021)

Case Commentary: Pope v. Lunday, No. 20-6003, 2020 U.S. App. LEXIS 36618 (10th Cir. Nov. 20, 2020)

Opioid Crisis: Biology, Neurobiology, and Chemistry of Opioid Use Disorder

Opioid Crisis: Summary

Opioid Crisis: Treatment of Incarcerated Individuals with Opioid Use Disorders

Opioid Crisis: Understanding the Issue

Opioid Crisis: Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings

Pages